FTI CONSULTING, INC (FCN) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $831.8K sold). Latest close $206.66 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 3, 2026 · Congress to Nov 16, 2026.
Torray Investment Partners LLC — 1 tracked fund hold FCN. See all holders.
Insiders bought on the open market (0 purchases, $0) vs 1 sale ($831.8K). Insider trading
Genpact LTD (G) · Booz Allen Hamilton Holding Corp (BAH) · ICF International, Inc. (ICFI) · ICON PLC (ICLR) · IQVIA HOLDINGS INC. (IQV) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Torray Investment Partners LLC | 0.27% | 13,500 | ADDED (+4.4%) Q3 filed Oct 30 |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: +37.6% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 377 of 8,857 filers |
| Long-only filers among them | 376 |
| Change vs 2026 Q1 | -19 net · 365 entered · 384 exited |
| Shares reported, all filers | 30,468,468 |
| Reported value, all filers | $4.2B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | Services-Management Consulting Services (SIC 8742) |
| Revenue · FY2025 | $3.8B |
| Net income · FY2025 | $270.9M |
| Total assets · FY2025 | $3.5B |
| Shares outstanding | 27,254,187 |
| Market cap (at latest close) | $5.6B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Oct 22, 2026.
| Shares short · Oct 15, 2026 | 3,053,194 |
| Share of shares outstanding | 11.20% |
| Days to cover | 7.01 |
Shares short at recent settlements — Jul 31, 2026: 2.4M · Aug 14, 2026: 2.3M · Aug 31, 2026: 2.9M · Sep 15, 2026: 3.0M · Sep 30, 2026: 3.2M · Oct 15, 2026: 3.1M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Oct 22, 2026.
| Shares failed to deliver · Oct 14, 2026 | 2 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | <0.1% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 9K · Aug 31, 2026: 2K · Sep 15, 2026: 0 · Sep 30, 2026: 7K · Oct 14, 2026: 2.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Oct 22, 2026.
0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 1 sale by 1 insider ($831.8K).
Source: SEC Form 4 filings. Open-market transactions only.
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | Linton Paul Alderman | Chief Strategy/Transf. Officer | Sell | 4,378 | $190.00 | $831.8K | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | ELSY BOGLIOLI | Director | 900 | $135.2K | Aug 11, 2026 | SEC filing |
| Mar 9, 2026 | CURTIS LU | Officer | 8,710 | $1.5M | Mar 9, 2026 | SEC filing |
| Jun 9, 2025 | CURTIS LU | Officer | 4,953 | $785.6K | Jun 9, 2025 | SEC filing |
| May 1, 2025 | SABHERWAL AJAY | Officer | 5,236 | $861.8K | May 1, 2025 | SEC filing |
| Aug 20, 2024 | Holthaus Gerard E | Director | 1,329 | $296.4K | Aug 20, 2024 | SEC filing |
| Jul 29, 2024 | Paul Holly | Officer | 4,078 | $922.6K | Jul 29, 2024 | SEC filing |
| May 21, 2024 | Paul Holly | Officer | 6,931 | $1.6M | May 21, 2024 | SEC filing |
| May 20, 2024 | SABHERWAL AJAY | Officer | 596 | $135.3K | May 20, 2024 | SEC filing |
| May 20, 2024 | SABHERWAL AJAY | Officer | 2,804 | $634.1K | May 20, 2024 | SEC filing |
| May 15, 2024 | Linton Paul Alderman | Officer | 3,127 | $691.1K | May 15, 2024 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | T. Rowe Price Associates, Inc. | SC 13G | 1,976,510 | 6.6% | Jun 30, 2026 | SEC filing |
| Aug 6, 2026 | FMR LLC | SC 13G/A | 1,210,542.05 | 4.0% | Jun 30, 2026 | SEC filing |
| Jul 24, 2026 | Victory Capital Management, Inc. | SC 13G/A | 1,489,979 | 4.9% | Jun 30, 2026 | SEC filing |
| May 12, 2026 | Mawer Investment Management Ltd. | SC 13G/A | 1,311,025 | 4.3% | Mar 31, 2026 | SEC filing |
| May 6, 2026 | FMR LLC | SC 13G | 1,546,983.52 | 5.1% | Mar 31, 2026 | SEC filing |
| Apr 29, 2026 | Vanguard Capital Management | SC 13G | 1,598,616 | 5.2% | Mar 31, 2026 | SEC filing |
| Mar 26, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Feb 11, 2026 | Mawer Investment Management Ltd. | SC 13G/A | 2,305,748 | 7.5% | Dec 31, 2025 | SEC filing |
| Jun 4, 2025 | BlackRock, Inc. | SC 13G/A | 3,076,672 | 9.0% | May 31, 2025 | SEC filing |
| May 6, 2025 | Kayne Anderson Rudnick Investment Management, LLC | SC 13G/A | 3,373,453 | 16.1% | Apr 30, 2025 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: Services-Management Consulting Services (SIC 8742). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Lobbying: 21 Lobbying Disclosure Act filings named this company as client, 2019–2025; most common issues: Energy/Nuclear (9), Defense (6), Tariff (miscellaneous tariff bills) (3).
Federal contracts: $58.3M in obligated amounts, fiscal years 2021–2026.
| Fiscal year | Obligated amount |
|---|---|
| FY2021 | $7.1M |
| FY2022 | $4.1M |
| FY2023 | $7.0M |
| FY2024 | $13.6M |
| FY2025 | $12.1M |
| FY2026 | $14.2M |
Largest awards collected
| Award ID | Agency | Amount | Start |
|---|---|---|---|
| DJJ12WENR010008 | Department of Justice | $31.8M | Oct 12, 2011 |
| IND15PD00546 | Department of the Interior | $11.1M | May 1, 2015 |
| 15JENR19P00000014 | Department of Justice | $9.8M | Oct 30, 2018 |
| DJJ17WENR010304 | Department of Justice | $6.1M | Sep 4, 2017 |
| 2023H225C00111 | Department of the Treasury | $4.7M | Aug 6, 2025 |
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
Financial Screens
· Growth — Revenue up every year for 5 straight years
· Graham — Sound finances and a long run of profits
· Greenblatt Magic Formula — High earnings yield and high return on capital together
· Shareholder Yield — Cash returned through dividends and buybacks
· Earnings Stability — Small earnings swings and almost no loss years
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
· 52-Week High — Recently printed a new 52-week high
· Top Relative Strength — Top 20% of the universe by 6-month return
Key figures
· Growth — Latest revenue: $3.8B · 5-yr revenue CAGR: 9.0% · Straight growth years: 8
· Graham — Current ratio: 1.56 · Straight profitable years: 12 · Debt ratio: 1.01 · Latest net income: $270.9M
· Greenblatt Magic Formula — Earnings yield: 5.2% · Return on capital: 54.7% · Combined rank: 79
· Shareholder Yield — Shareholder yield: 14.4% · of which dividends: 0.0% · of which buybacks: 14.4%
· Earnings Stability — Earnings variation (CV): 0.32 · Loss years (of 10): 0 · Latest net income: $270.9M
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Insider BEST — appeared in 1 of the last 20 quarterly lists; latest 2026 Q2, ranked #43 of 50.
Also held by the tracked funds that hold FCN — ranked by lift, the co-holding pattern described in Methodology: Genpact LTD (G) · Booz Allen Hamilton Holding Corp (BAH) · ICF International, Inc. (ICFI) · ICON PLC (ICLR) · IQVIA HOLDINGS INC. (IQV) · VSE CORP (VSEC) · Medpace Holdings, Inc. (MEDP) · CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
| Filed | Items | Source |
|---|---|---|
| Oct 30, 2026 | 2.02 Results of Operations and Financial Condition · 2.05 Costs Associated with Exit or Disposal Activities · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
| Jul 31, 2026 | 2.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
| Jul 1, 2026 | 1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
Genpact LTD (G) · Track Record: how the signals scored · Practice timing on FCN
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.